Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

(MedPage Today) — SAN FRANCISCO — A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre…